ACAD8

acyl-CoA dehydrogenase family member 8, the group of Acyl-CoA dehydrogenase family

Basic information

Region (hg38): 11:134253548-134265855

Links

ENSG00000151498NCBI:27034OMIM:604773HGNC:87Uniprot:Q9UKU7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • isobutyryl-CoA dehydrogenase deficiency (Strong), mode of inheritance: AR
  • isobutyryl-CoA dehydrogenase deficiency (Strong), mode of inheritance: AR
  • isobutyryl-CoA dehydrogenase deficiency (Supportive), mode of inheritance: AR
  • isobutyryl-CoA dehydrogenase deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Isobutyryl-CoA dehydrogenase deficiencyARBiochemicalMetabolic precautions may be beneficial to prevent and treat acute decompensation; Medical treatment (eg, with oral L-carnitine) has been reported as allowing growth catch-up and normalization of cardiac statusBiochemical; Cardiovascular; Hematologic; Musculoskeletal; Neurologic9889013; 12359132; 17304052; 16857760; 17924841; 21290185; 22241096

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ACAD8 gene.

  • Deficiency_of_isobutyryl-CoA_dehydrogenase (182 variants)
  • not_provided (75 variants)
  • Inborn_genetic_diseases (42 variants)
  • not_specified (8 variants)
  • ACAD8-related_disorder (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACAD8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014384.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
10
clinvar
27
clinvar
1
clinvar
38
missense
5
clinvar
17
clinvar
105
clinvar
10
clinvar
1
clinvar
138
nonsense
6
clinvar
2
clinvar
1
clinvar
9
start loss
4
4
frameshift
3
clinvar
3
splice donor/acceptor (+/-2bp)
4
clinvar
4
clinvar
3
clinvar
11
Total 18 27 119 37 2

Highest pathogenic variant AF is 0.00023606591

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ACAD8protein_codingprotein_codingENST00000281182 1112361
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.64e-140.05531256780701257480.000278
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2222212310.9590.00001322701
Missense in Polyphen8993.7270.949561080
Synonymous-1.9511591.31.260.00000562823
Loss of Function0.5082224.70.8900.00000156246

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005610.000561
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00009240.0000924
European (Non-Finnish)0.0003500.000334
Middle Eastern0.0001630.000163
South Asian0.0003270.000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has very high activity toward isobutyryl-CoA. Is an isobutyryl-CoA dehydrogenase that functions in valine catabolism. Plays a role in transcriptional coactivation within the ARC complex. {ECO:0000269|PubMed:12359132}.;
Pathway
Valine, leucine and isoleucine degradation - Homo sapiens (human);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Maple Syrup Urine Disease;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;Metabolism;valine degradation (Consensus)

Recessive Scores

pRec
0.250

Intolerance Scores

loftool
0.287
rvis_EVS
-0.38
rvis_percentile_EVS
27.88

Haploinsufficiency Scores

pHI
0.0217
hipred
N
hipred_score
0.289
ghis
0.530

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.992

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Acad8
Phenotype
adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; liver/biliary system phenotype; renal/urinary system phenotype;

Gene ontology

Biological process
valine catabolic process;lipid metabolic process;branched-chain amino acid catabolic process;oxidation-reduction process
Cellular component
mitochondrial matrix
Molecular function
acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding